MIRA Pharmaceuticals (MIRA) announced results demonstrating that its oral drug candidate Ketamir-2 restored normalized behavior in stressed animals within a validated model of post-traumatic stress ...

MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD ...

Autism assessment still often leaves lived experience unheard and unseen by focusing almost exclusively on outwardly observable behaviours.